Table 2: Comparison of baseline between Low PP group and High PP group in CKD stage G3a-G3b.
Values are mean ± standard deviation where appropriate.
| Characteristics | Low PP group (n=42) | High PP group (n=16) | p value |
| Age (y) | 64.0±11.5 | 69.6±8.4 | 0.0833 |
| Gender n (%) | | | 0.7654 |
| Male | 28 (66.7%) | 10 (62.5%) | |
| Female | 14 (33.3%) | 6 (37.5%) | |
| Body weight (kg) | 64.3±13.7 | 68.1±13.9 | 0.3807 |
| Body mass Index (kg/m2) | 24.6±3.4 | 27.0±7.3 | 0.3855 |
| Smoking history n (%) | 17 (44.7) | 9 (60.0) | 0.3167 |
| Comorbidity |
| Diabetes Mellitus n (%) | 6 (37.5) | 14 (33.3) | 0.7654 |
| Hypertension n (%) | 12 (75.0) | 28 (66.7) | 0.5398 |
| Clinical laboratory data |
| SBP (mmHg) | 126.2±13.4 | 147.0±12.6 | <.0001 |
| DBP (mmHg) | 76.1±10.5 | 73.2±10.8 | 0.0677 |
| AST (IU/L) | 28.7±17.1 | 25.8±14.7 | 0.3507 |
| ALT (IU/L) | 26.7±16.3 | 18.3±7.7 | 0.0228 |
| SUA (mg/dL) | 6.9±1.4 | 7.5±1.5 | 0.3935 |
| BUN (mg/dL) | 19.5±6.7 | 23.8±8.5 | 0.0430 |
| SCr (mg/dL) | 1.1±0.3 | 1.3±0.4 | 0.2437 |
| Ccr (mL/min) | 58.4±23.4 | 50.8±15.7 | 0.2542 |
| eGFR (mL/min/1.73m2) | 48.1±11.5 | 41.9±11.5 | 0.0744 |
| TC (mg/dL) | 173.8±28.7 | 177.0±24.3 | 0.7260 |
| HDL-C (mg/dL) | 54.5±28.1 | 51.1±16.2 | 0.9820 |
| LDL-C (mg/dL) | 85.2±22.6 | 90.5±23.7 | 0.3547 |
| TG (mg/dL) | 161.2±74.9 | 190.6±86.8 | 0.2888 |
| Alb (g/dL) | 4.0±0.4 | 3.7±0.6 | 0.3720 |
| K (mEq/L) | 4.3±0.5 | 4.3±0.4 | 0.8496 |
| Hb (g/dL) | 13.5±2.1 | 12.5±1.3 | 0.0647 |
| Ht (%) | 40.0±6.1 | 34.7±9.1 | 0.0545 |
| HbA1c (NGSP) (%) | 6.3±0.7 | 6.5±0.9 | 0.4491 |